Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Cancer ; 72(8): 1255-1263, 2020.
Article in English | MEDLINE | ID: mdl-31635488

ABSTRACT

The aim of the study was to investigate the association between blood and tissue levels of selenium and thyroid cancer through a systematic review. We searched for observational studies written in English, Spanish, and Portuguese indexed in PubMed, LILACS, and Scielo without date restriction, that evaluated the association between selenium levels in whole-blood, serum, or plasma and/or thyroid tissue and thyroid cancer, both in individuals with cancer of thyroid as in healthy individuals. Then data were extracted and analyzed. Of the 570 articles identified, five cross-sectional studies were included in the review. In one study, lower concentrations of selenium were found in whole-blood (0.543 µg/ml) and in the thyroid (0.88 µg/g) of thyroid cancer patients compared to controls. Another study showed a decrease in serum selenium concentrations in patients with follicular carcinoma and papillary types (0.077 ± 0.021 µg/ml and 0.080 ± 0.020 µg/ml, respectively). On the other hand, other studies showed no difference in plasma selenium content or glutathione peroxidase activity among patients and healthy volunteers. The available evidence on this issue is inconclusive. Additional studies are needed to elucidate the association between serum and/or tissue levels of selenium and the development of thyroid cancer.


Subject(s)
Selenium/metabolism , Thyroid Gland/metabolism , Thyroid Neoplasms/metabolism , Animals , Antioxidants/metabolism , Case-Control Studies , Cross-Sectional Studies , Humans , Selenium/blood , Thyroid Gland/pathology , Thyroid Neoplasms/blood , Thyroid Neoplasms/pathology
2.
Appetite ; 60(1): 203-207, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23088901

ABSTRACT

It has been suggested that the use of nonnutritive sweeteners (NNSs) can lead to weight gain, but evidence regarding their real effect in body weight and satiety is still inconclusive. Using a rat model, the present study compares the effect of saccharin and aspartame to sucrose in body weight gain and in caloric intake. Twenty-nine male Wistar rats received plain yogurt sweetened with 20% sucrose, 0.3% sodium saccharin or 0.4% aspartame, in addition to chow and water ad libitum, while physical activity was restrained. Measurements of cumulative body weight gain, total caloric intake, caloric intake of chow and caloric intake of sweetened yogurt were performed weekly for 12 weeks. Results showed that addition of either saccharin or aspartame to yogurt resulted in increased weight gain compared to addition of sucrose, however total caloric intake was similar among groups. In conclusion, greater weight gain was promoted by the use of saccharin or aspartame, compared with sucrose, and this weight gain was unrelated to caloric intake. We speculate that a decrease in energy expenditure or increase in fluid retention might be involved.


Subject(s)
Aspartame/administration & dosage , Saccharin/administration & dosage , Sucrose/administration & dosage , Weight Gain/drug effects , Animals , Energy Intake , Energy Metabolism , Male , Rats , Rats, Wistar , Satiation/drug effects , Sweetening Agents/administration & dosage , Yogurt
SELECTION OF CITATIONS
SEARCH DETAIL
...